Literature DB >> 27534556

Human Invariant NKT Cells Induce IL-1β Secretion by Peripheral Blood Monocytes via a P2X7-Independent Pathway.

Laura E Felley1, Akshat Sharma1, Erin Theisen1, James C Romero-Masters2, John-Demian Sauer1, Jenny E Gumperz3.   

Abstract

The cytokine IL-1β plays a central role in inflammatory responses that are initiated by microbial challenges, as well as in those that are due to endogenous processes (often called sterile inflammation). IL-1β secretion that occurs independently of microbial stimulation is typically associated with the presence of endogenous alarmins, such as extracellular ATP (an indicator of cytopathic damage). In this study, we show that IL-2-activated human invariant NKT (iNKT) cells stimulate the secretion of IL-1β protein by human peripheral blood monocytes in a manner that requires neither the presence of microbial compounds nor signaling through the extracellular ATP receptor P2X7 Monocyte IL-1β production was specifically induced by iNKT cells, because similarly activated polyclonal autologous T cells did not have this effect. Secretion of IL-1β protein occurred rapidly (within 3-4 h) and required cell contact between the iNKT cells and monocytes. Similar to IL-1β production induced by TLR stimulation, the iNKT-induced pathway appeared to entail a two-step process involving NF-κB signaling and IL1B gene transcription, as well as assembly of the NLRP3 inflammasome and activation of caspase-1. However, in contrast to the classical inflammasome-mediated pathway of IL-1β production, activation of monocytes via P2X7 was dispensable for iNKT-induced IL-1β secretion, and potassium efflux was not required. Moreover, the iNKT-induced effect involved caspase-8 activity, yet it induced little monocyte death. These results suggest that IL-2-activated human iNKT cells induce monocytes to produce IL-1β through a distinctive pathway that does not require the presence of microbial danger signals or alarmins associated with cytopathic damage.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27534556      PMCID: PMC5011004          DOI: 10.4049/jimmunol.1600790

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

Review 2.  P2X receptors as cell-surface ATP sensors in health and disease.

Authors:  Baljit S Khakh; R Alan North
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

3.  Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques.

Authors:  Yuri V Bobryshev; Reginald S A Lord
Journal:  J Histochem Cytochem       Date:  2005-06       Impact factor: 2.479

Review 4.  Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease.

Authors:  Yue Zheng; Sarah E Gardner; Murray C H Clarke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12       Impact factor: 8.311

5.  Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice.

Authors:  Amy S Major; Michael T Wilson; Jennifer L McCaleb; Yan Ru Su; Aleksandar K Stanic; Sebastian Joyce; Luc Van Kaer; Sergio Fazio; Macrae F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-07       Impact factor: 8.311

Review 6.  The role of IL-1 in the pathogenesis of heart disease.

Authors:  Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-05-29       Impact factor: 4.291

7.  NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.

Authors:  Kori L Wallace; Melissa A Marshall; Susan I Ramos; Joanne A Lannigan; Joshua J Field; Robert M Strieter; Joel Linden
Journal:  Blood       Date:  2009-05-11       Impact factor: 22.113

8.  Recognition of lyso-phospholipids by human natural killer T lymphocytes.

Authors:  Lisa M Fox; Daryl G Cox; Jennifer L Lockridge; Xiaohua Wang; Xiuxu Chen; Louise Scharf; David L Trott; Rachel M Ndonye; Natacha Veerapen; Gurdyal S Besra; Amy R Howell; Mark E Cook; Erin J Adams; William H Hildebrand; Jenny E Gumperz
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

9.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Authors:  Rebecca C Coll; Avril A B Robertson; Jae Jin Chae; Sarah C Higgins; Raúl Muñoz-Planillo; Marco C Inserra; Irina Vetter; Lara S Dungan; Brian G Monks; Andrea Stutz; Daniel E Croker; Mark S Butler; Moritz Haneklaus; Caroline E Sutton; Gabriel Núñez; Eicke Latz; Daniel L Kastner; Kingston H G Mills; Seth L Masters; Kate Schroder; Matthew A Cooper; Luke A J O'Neill
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

10.  Determination of cellular lipids bound to human CD1d molecules.

Authors:  Daryl Cox; Lisa Fox; Runying Tian; Wilfried Bardet; Matthew Skaley; Danijela Mojsilovic; Jenny Gumperz; William Hildebrand
Journal:  PLoS One       Date:  2009-05-05       Impact factor: 3.240

View more
  9 in total

Review 1.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

Review 2.  How Inflammasomes Inform Adaptive Immunity.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

Review 3.  Alternative inflammasome activation enables IL-1β release from living cells.

Authors:  Moritz M Gaidt; Veit Hornung
Journal:  Curr Opin Immunol       Date:  2016-11-11       Impact factor: 7.486

Review 4.  Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

Authors:  Melissa Bedard; Mariolina Salio; Vincenzo Cerundolo
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

5.  P2X1, P2X4, and P2X7 Receptor Knock Out Mice Expose Differential Outcome of Sepsis Induced by α-Haemolysin Producing Escherichia coli.

Authors:  Anne-Sofie Greve; Marianne Skals; Steen K Fagerberg; Wulf Tonnus; Svend Ellermann-Eriksen; Richard J Evans; Andreas Linkermann; Helle A Praetorius
Journal:  Front Cell Infect Microbiol       Date:  2017-04-06       Impact factor: 5.293

Review 6.  ATP-Binding and Hydrolysis in Inflammasome Activation.

Authors:  Christina F Sandall; Bjoern K Ziehr; Justin A MacDonald
Journal:  Molecules       Date:  2020-10-07       Impact factor: 4.411

7.  NKT cells promote both type 1 and type 2 inflammatory responses in a mouse model of liver fibrosis.

Authors:  Julia Nilsson; Maria Hörnberg; Anja Schmidt-Christensen; Kajsa Linde; Maria Nilsson; Marine Carlus; Saskia F Erttmann; Sofia Mayans; Dan Holmberg
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

Review 8.  The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in Tissues.

Authors:  Filippo Cortesi; Gloria Delfanti; Giulia Casorati; Paolo Dellabona
Journal:  Front Immunol       Date:  2018-10-12       Impact factor: 7.561

9.  A Two-Cell Model for IL-1β Release Mediated by Death-Receptor Signaling.

Authors:  Carlos A Donado; Anh B Cao; Daimon P Simmons; Ben A Croker; Patrick J Brennan; Michael B Brenner
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.